Parabilis Raises $305M to Advance First-in-Class Cancer Therapies
Cambridge, Massachusetts — January 8, 2026 — Parabilis Medicines announced the successful close of an oversubscribed $305 million Series...
Wnt Beta-Catenin
Advertisement
Advertisement
